SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-20-027119
Filing Date
2020-02-28
Accepted
2020-02-28 16:17:40
Documents
64
Period of Report
2019-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm205231d1_10k.htm 10-K 832106
2 EXHIBIT 4.4 tm205231d1_ex4-4.htm EX-4.4 14903
3 EXHIBIT 31 tm205231d1_ex31.htm EX-31 12611
4 EXHIBIT 32 tm205231d1_ex32.htm EX-32 4905
  Complete submission text file 0001104659-20-027119.txt   5512942

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT qbio-20191130.xml EX-101.INS 1297242
6 XBRL TAXONOMY EXTENSION SCHEMA qbio-20191130.xsd EX-101.SCH 48053
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qbio-20191130_cal.xml EX-101.CAL 29152
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qbio-20191130_def.xml EX-101.DEF 190225
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE qbio-20191130_lab.xml EX-101.LAB 421119
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qbio-20191130_pre.xml EX-101.PRE 339977
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-K | Act: 34 | File No.: 000-55535 | Film No.: 20670365
SIC: 2834 Pharmaceutical Preparations